Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
Liat Rousso-Noori, Ignacio Mastandrea, Shauli Talmor, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

mRNA-Laden Lipid-Nanoparticle-Enabled in Situ CAR-Macrophage Engineering for the Eradication of Multidrug-Resistant Bacteria in a Sepsis Mouse Model
Chunwei Tang, Weiqiang Jing, Kun Han, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 2261-2278
Closed Access | Times Cited: 21
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Tessa Gargett, Lisa M. Ebert, Nga Truong, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005187-e005187
Open Access | Times Cited: 60
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Francisco Branco, Joana Cunha, Maria Mendes, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16359-16394
Open Access | Times Cited: 12
A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats
Lorea Iturri, Emmanuel Jouglar, Cristèle Gilbert, et al.
Clinical and Translational Radiation Oncology (2025) Vol. 51, pp. 100911-100911
Closed Access | Times Cited: 1
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma
Sheridan L. Swan, Nalini Mehta, Ekaterina Ilich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
Alessia Pellerino, Francesco Bruno, Riccardo Soffietti, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 7, pp. 777-785
Open Access | Times Cited: 17
Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening
Xing Li, Shiyu Sun, Wansong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy
Yan Liu, Dan Zhang, Zongquan Zhang, et al.
Journal of Colloid and Interface Science (2023) Vol. 657, pp. 598-610
Closed Access | Times Cited: 16
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
Kimia Kardani, Judit Sánchez Gil, Samuel D. Rabkin
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
Microbiota and glioma: a new perspective from association to clinical translation
Wenhui Wang, Zihao Ou, Xixin Huang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds
Sweety Asija, Abhishek Chatterjee, Sandhya Yadav, et al.
International Reviews of Immunology (2022) Vol. 41, Iss. 6, pp. 582-605
Closed Access | Times Cited: 22
CAR T-Cell Therapy in Children with Solid Tumors
Marika Kulczycka, Kamila Derlatka, Justyna Tasior, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2326-2326
Open Access | Times Cited: 12
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
Sara W. Feigelson, Tali Dadosh, Nehora Levi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in CAR-T therapy for central nervous system tumors
Delian Zhou, Xiaojian Zhu, Yi Xiao
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis
Quiñones-Díaz BI, Jun Nie, Qiang Wu, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer
Carlos Alejandro Egusquiza-Alvarez, Martha Robles‐Flores
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 8, pp. 1831-1854
Closed Access | Times Cited: 16
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
Rui Sun, Albert H. Kim
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 4, pp. 871-898
Open Access | Times Cited: 15
gC1qR: A New Target for Cancer Immunotherapy
Yanna Lei, Xiaoyu Li, Diyuan Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma
Deepkumar Bagasariya, Kondasingh Charankumar, Saurabh Shah, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 177, pp. 157-174
Closed Access | Times Cited: 14
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D
Shanglin Li, Ruocong Zhao, Di‐Wei Zheng, et al.
Molecular Therapy — Oncolytics (2022) Vol. 26, pp. 15-26
Open Access | Times Cited: 12
New avenues for cancer immunotherapy: Cell-mediated drug delivery systems
Huan Zhang, Adam Grippin, Man Sun, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 712-732
Closed Access | Times Cited: 2
Site-Specific Considerations on Engineered T Cells for Malignant Gliomas
Nirmeen Elmadany, Obada Alhalabi, Michael Platten, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1738-1738
Open Access | Times Cited: 11
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
Peng Zhang, Yang Zhang, Nan Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top